Encora Therapeutics
encoratherapeutics.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Encora Therapeutics Receives FDA 510(k) Clearance for Encora X1, a Breakthrough Wearable Device for Essential Tremor
BOSTON, February 12, 2026--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1.
Read more
Report
Encora Therapeutics Receives FDA 510(k) Clearance for Encora X1, a Breakthrough Wearable Device for Essential Tremor
BOSTON, February 12, 2026--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Encora X1.
Read more
Report
Daily News
The Los Angeles Daily News is the local news source for Los Angeles and the San Fernando Valley region, providing breaking news, sports, business, entertainment, things to do, opinion, photos, videos and more from L.A.
Read more
Report
Encora Therapeutics Names Nadim Yared as Chairman and Chief Executive Officer
BOSTON, October 02, 2025--Encora Therapeutics, a clinical-stage medtech company developing a neuromodulation therapy for movement disorders, today announced the appointment of Nadim Yared as Chairman and Chief Executive Officer, effective immediately. Co-
Read more
Report
Report